Sanofi pe­ti­tions FDA over 'mis­lead­ing' la­bel for ri­val flu vac­cine that failed to con­firm ben­e­fit

Sanofi is call­ing on the FDA to change the la­bels for CSL Lim­it­ed sub­sidiary Se­qirus’ flu vac­cines, which won ac­cel­er­at­ed ap­provals but have failed to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.